Here’s an overview of six stocks, including their exchange, recent performance, and a brief description. This post is for information and personal discovery purposes. It is not an indicator to buy, sell, or hold to any of these stocks. Stock prices are volatile and subject to rapid changes. It’s advisable to consult financial advisors or use real-time trading platforms for the most current information. The stock performance summaries are based on general trends observed over the past ten trading days and are not indicative of future results.
Exchange: NYSE
52 Week High: ~$972.48 | 52 Week Low: ~$623.78
Current Price: ~$710.60
Recent Performance: Down ~8% over the past month after a sharp drop on Aug. 7 tied to disappointing orforglipron pill data, followed by a partial rebound last week.
Description: Lilly is a global pharma leader; its GLP-1/GIP franchise (Mounjaro for diabetes, Zepbound for obesity) is driving rapid growth, with Q2 2025 revenue up ~38% to $15.56B. The company is expanding access/form factors (e.g., single-dose Zepbound vials) and continues to invest behind obesity leadership.
Sector: Healthcare / Pharmaceuticals
Bullish Or Bearish: Cautiously Bullish — despite the orforglipron setback, consensus commentary still sees Lilly as a long-term winner in obesity/diabetes therapies.
Exchange: Nasdaq
52 Week High: ~$2.40 | 52 Week Low: ~$1.26
Current Price: ~$1.97
Recent Performance: Roughly flat to down ~2–3% over the last month, consolidating around the $2 level.
Description: Marchex provides AI-powered conversation intelligence — analyzing voice/text customer interactions to improve marketing attribution and sales execution. Recent updates highlight vertical solutions and generative-AI call summaries.
Sector: Technology / Software (Conversation Analytics)
Bullish Or Bearish: Neutral — small-cap with mixed technicals and modest revenue base; wait for sustained growth acceleration or stronger adoption signals.
Exchange: Nasdaq
52 Week High: ~$63.20 | 52 Week Low: ~$21.20
Current Price: ~$30.68
Recent Performance: Up ~18% over the past month after bouncing off early-August 52-week lows.
Description: Astrana (formerly Apollo Medical) is a provider-centric, technology-powered, risk-bearing platform for value-based care serving ~1.1 million patients across ~10,000 providers. It operates MSOs, IPAs/ACOs and care-delivery entities on a population-health platform.
Sector: Healthcare / Managed Care & Physician Services
Bullish Or Bearish: Cautiously Bullish — shares trade well below 52-week highs and sit under an average Street target around $43, implying upside if execution improves.
Exchange: Nasdaq & TSX (as DOO)
52 Week High: ~$72.84 | 52 Week Low: ~$31.78
Current Price: ~$58.39
Recent Performance: Up ~16% over the past month and ~61% over three months, reflecting a strong rebound in leisure-vehicle sentiment.
Description: BRP designs and manufactures powersports vehicles and marine products under brands like Ski-Doo, Sea-Doo, and Can-Am, with a global manufacturing footprint.
Sector: Consumer Discretionary / Leisure Products
Bullish Or Bearish: Neutral — after a sharp run, analyst targets cluster around the low-to-mid $50s, suggesting limited near-term upside from current levels.
Exchange: Nasdaq
52 Week High: ~$5.00 | 52 Week Low: ~$1.36
Current Price: ~$4.18
Recent Performance: Up ~18% over the past month, pushing into the upper half of its 52-week range.
Description: Nephros makes ultrafiltration products that help hospitals and dialysis centers remove waterborne pathogens (e.g., legionella, pseudomonas) and contaminants from water systems. Its FDA-cleared filters target infection control and dialysis water quality.
Sector: Healthcare / Medical Devices (Water Filtration)
Bullish Or Bearish: Speculative Neutral — momentum has improved (big 52-week gain), but coverage is thin and micro-cap liquidity/volatility remains high.
Exchange: NYSE & TSX
52 Week High: ~$57.70 | 52 Week Low: ~$44.09
Current Price: ~$57.63
Recent Performance: Modestly higher over the past month (≈+2%), hovering near 52-week highs.
Description: Scotiabank is one of North America’s largest banks (~CA$1.4T in assets as of Apr. 30, 2025) with operations spanning Canadian Banking, International Banking, Global Wealth Management, and Global Banking & Markets. It trades on both the TSX (BNS) and NYSE (BNS).
Sector: Financials / Banks — Diversified
Bullish Or Bearish: Neutral (income-tilted) — consensus skews Hold with an attractive ~5.7% forward dividend yield but limited near-term upside in targets.
THIS NEWSLETTER IS PARTNERED WITH ROBINHOOD.COM AND IS FINANCIALLY SPONSORED BY THAT SERVICE.
TO BEGIN YOUR INVESTMENT JOURNEY TODAY, USE THIS LINK TO SET UP YOUR ACCOUNT.
Leave a Reply